GlassScriptPhysician profile
Jenessa Horton
NPI 1932713419
$432.12
in general payments reported to CMS, 2019-2025
19 companies · $33.94 in 2025
The $33.94 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $95.89 · 2023: $52.73 · 2025: $33.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $56.04 | 2021-2022 | |
| Astellas Pharma US INC | $46.90 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $42.06 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.97 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $25.08 | 2022 | |
| Edwards Lifesciences Corporation | $22.69 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Sobi, INC | $19.65 | 2025 | |
| Abbvie INC. | $19.57 | 2021 | |
| Lilly USA, LLC | $18.43 | 2021 | |
| Glaxosmithkline, LLC. | $18.42 | 2021 | |
| Amgen INC. | $16.69 | 2022 | |
| Neurelis, INC. | $16.63 | 2021 | |
| Upsher-Smith Laboratories LLC | $15.89 | 2021 | |
| Genentech USA, INC. | $15.85 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $15.33 | 2023 | Rexulti, Abilify Maintena |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $15.15 | 2021 | |
| Organon LLC | $14.29 | 2025 | Nexplanon, Nuvaring |
| Qiagen, LLC | $13.75 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenessa Horton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.